Epsium Stock Climbs in Pre-Market as Macau Liquor Firm Brushes Off Tech Selloff

Epsium Stock Climbs in Pre-Market as Macau Liquor Firm Brushes Off Tech Selloff

June 5, 2026

New York, June 5, 2026, 05:09 (EDT)

  • Epsium traded at $1.65 before the open, after finishing Thursday at $1.64, up 5.13%.
  • Nasdaq was still closed to regular trading. Orders for regular hours go from 9:30 a.m. to 4:00 p.m. Eastern.
  • Nasdaq futures slipped, and the broader tape traded weaker ahead of the May U.S. jobs numbers.

Epsium Enterprise Ltd traded up in early U.S. premarket action Friday, adding to its recent jump. Shares in the Nasdaq-listed Macau liquor wholesaler rose even as tech futures slipped.

The stock was last at $1.65 at 4:52 a.m. ET, a 0.61% rise from the $1.64 close on Thursday. Shares added 5.13% in the previous regular session, according to Investing.com data.

Timing is the issue here. Nasdaq was still closed for its regular session, with trading hours running 9:30 a.m. to 4:00 p.m. Eastern. Early moves can shift before regular liquidity shows up. Nasdaq’s 2026 holiday calendar doesn’t have June 5 marked as a closure; Juneteenth on June 19 is the holiday that month.

The market backdrop turned rougher. Global stocks slipped Friday, Reuters said, as investors took a defensive stance. Nasdaq futures were down 1.2%, S&P 500 futures off 0.6% ahead of U.S. nonfarm payrolls. The Labor Department lists the May Employment Situation release for 8:30 a.m. Eastern.

Epsium trades as a micro-cap, with StockTitan estimating its market cap at about $20.9 million. The stock is still down around 90% over the last year after a sharp decline. Boursorama’s FactSet-backed page shows shares climbing 35.54% in a week but still down 90.47% for the year.

Epsium isn’t a direct stand-in for the large global spirits groups. The firm does business through a Macau company that brings in and wholesales mostly alcohol, focusing on Chinese liquor. Brands like Diageo and Pernod Ricard run much bigger operations and sell a wider range of premium drinks worldwide.

Epsium began trading on Nasdaq in 2025. The company said its IPO priced at $4.00 per share and netted $4.91 million including the over-allotment. Premarket on Friday, the stock was still under the IPO price despite a recent bounce.

Epsium’s first-half 2025 results were a mixed bag. Revenue dropped to $3.04 million from $7.11 million a year ago, which the company said was due to the timing of customer orders and efforts to optimize inventory. Gross margin edged up to 16.28%, compared with 13.09% last year. Epsium posted an operating loss of $0.69 million.

Epsium Chairman and CEO Son I Tam called fiscal 2025 an “important milestone” as the company finished its Nasdaq listing, but said revenue showed a “more challenging market environment” on the wholesale side. Tam said Epsium aims to grow higher-margin businesses like casinos and hotels. PR Newswire

Management is also working to strengthen finance operations. Ching Wan Wong was recently appointed CFO. Son said Wong’s “SEC reporting and cross-border financial compliance” background will help Epsium as a Nasdaq-listed company. Investing

But things can shift fast. Premarket gains could disappear after the open, more so for a thinly traded stock, and Epsium’s numbers show sales swing a lot on when customers place orders. Governance remains a problem for outsiders: an April SEC filing said Son I Tam held 98.79% of voting power through Class B stock, which gives 20 votes per share.

Dilution remains a risk, since if Epsium issues new shares, existing holders might end up with a smaller stake. Epsium registered 2,687,600 Class A ordinary shares for its 2026 share incentive plan in a May SEC filing.

Right now, it’s a price move before anything else on the stock. Fundamentals aren’t leading. A follow-through here probably needs more volume once the cash market opens at 9:30 a.m., or a more obvious company news catalyst. Without that, today’s pop is just part of the stock’s jumpy post-listing range. The jobs report and Nasdaq futures are driving the tone before the open.

Stock Market Today

  • ASX Small Caps Drive Growth in Biotech and Defense Sectors
    June 5, 2026, 5:37 AM EDT. Several ASX small-cap companies are turning emerging themes like biotechnology and defense into growth opportunities. These firms capitalize on innovative technologies and market needs, reflecting broader trends in investment focus. While these companies present potential for significant returns, investors should conduct thorough due diligence and consult financial advisers before committing capital. The landscape highlights the evolving role of small caps in Australia's market, generating interest for those seeking high growth in niche sectors.